Fundraising FoxTelegraph Hill Partners — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Cell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine.
BiotechDeep TechHardwareMedical DevicesDurham, US
Scott McGinnis(President)inNancy Allbritton(Director)Yuli Wang(Director)Matthew Megaro(Director)Gary Pace(Executive Officer, Director)Christopher Sims(Executive Officer, Director)
Board seatDeval LashkariRob Capone· per SEC Form D
Co-investorsNC IDEA
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Community BioExcellos
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.